An embattled camp for at-risk and troubled youth is set to close, the Maryland National Guard said Friday. The National Guard Bureau directed the Maryland National Guard to cease operations of the ...

The Texas Longhorns are no strangers to making or rewriting history, as the Longhorns softball program rewrites another chapter of its history on Friday night. The Longhorns headed into a two-game ...

At 20 airports in the United States, security screening is handled not by the Transportation Security Administration, but by private companies — and their checkpoints aren’t seeing long lines.

The company will continue to distribute library content, but will end production of first-run syndicated programming in a strategic shift. By Alex Weprin Senior Editor “NBCUniversal is making changes ...

New kinds of aircraft, sorts of “flying cars” that can take off and land with little space like helicopters but function like airplanes, will start operating in US airspace as early as June, the US ...

Nursing home patients are more likely to die in the facility or in hospice than in a hospital in states with mature POLST programs, according to a new, first-of-its kind study. Physician Orders for ...

Apache Geode has been revived after a near shutdown. The project’s contributor base thinned, development stalled, and the PMC voted to terminate the project in 2024 before work resumed and culminated ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.